Data are discussed which demonstrate that insulin plays an important role in sodium metabolism. The primary action of insulin on sodium balance is exerted on the kidney. Increases in plasma insulin concentration within the physiological range stimulate sodium reabsorption by the distal nephron segments and this effect is independent of changes in circulating metabolites or other hormones. Several clinical situations are reviewed: sodium wasting in poorly controlled diabetics, natriuresis of starvation, anti-natriuresis of refeeding and hypertension of obesity, in which insulin-mediated changes in sodium balance have been shown to play an important pathophysiological role.
Insulin and Sodium
The studies of Atchley et al. [1] were the first to suggest that insulin could affect renal sodium handling. Following the abrupt withdrawal of insulin therapy in patients with diabetes mellitus, they demonstrated a marked increase in sodium excretion which appeared to be in excess of the observed glycosuria and occurred before the development of ketonuria. Reinstitution of insulin therapy resulted in a marked reduction in sodium excretion, again unrelated to changes in glycosuria or ketonuria. However, changes in the filtered load of glucose and sodium, extracellular fluid volume, glomerular filtration rate (GFR) and renal plasma flow (RPF), as well as possible changes in aldosterone secretion due to changes in fluid volume, may have conspired to alter sodium excretion in these patients. In a more adequately controlled study, Miller and Bogdonoff [2] observed a reduction in urinary sodium excretion after insulin administration to normal subjects undergoing either a solute (glucose) diuresis or a water diuresis. Studies carried out on fasted obese subjects also suggested an effect of insulin on renal sodium transport [3] [4] [5] . After prolonged fasting, refeeding with carbohydrate, which results in both hyperinsulinaemia and hyperglycaemia, leads to marked retention of sodium by the kidney. However, these studies do not differentiate between an effect of hyperglycaemia versus hyperinsulinaemia on renal electrolyte transport. The ability of insulin in vitro to increase the short circuit current (a measure of sodium transport) across amphibian epithelia [6] [7] [8] [9] [10] suggested that it was the hyperinsulinaemia per se and not the hyperglycaemia that was responsible for the stimulation of sodium transport in the previously discussed clinical situations. It should be noted that the toad bladder and other amphibian epithelia possess electrolyte transporting characteristics similar to the mammalian distal tubule.
Hyperglycaemia, Hyperinsulinaemia, and Sodium Transport by the Kidney
To examine the differential effects of hyperglycaemia versus hyperinsulinaemia on whole kidney and seg-0012-186X/81/0021/0165/$01.40 mental renal sodium transport [11] , we have employed the glucose clamp technique [12] in combination with recollection micropuncture techniques. Three groups of dogs were studied (Fig. 1 (Fig. 1 , third column) demonstrate that it is hyperinsulinaemia per se, and not hyperglycaemia, which is responsible for the sodium retentive effects. Despite unchanged plasma glucose levels, insulin resulted in a greater than 50% decline in renal sodium excretion. This study, however, does not differentiate between a direct effect of insulin on sodium transport and one secondary to a stimulation of insulin-mediated glucose metabolism.
Tubular Localization of Insulin Action
In order to delineate the renal tubular segments involved in sodium transport, we have [11] inserted micropipettes into the proximal tubule to collect tubular fluid samples pre and post alteration of the plasma glucose and insulin levels ( change in the fractional delivery (TF/P)Na/IN of sodium to the proximal convoluted tubule as a function of time. In contrast, both hyperglycaemic hyperinsulinaemia (second column) and euglycaemic hyperinsulinaemia led to enhanced delivery of sodium out of the proximal tubule, i.e. inhibited proximal tubular reabsorption. Nonetheless, whole kidney sodium excretion fell by 35-50% (Fig. 2 , top panel). These results indicate that the effect of insulin on sodium reabsorption must occur in more distal parts of the nephron, i.e. par recta of the proximal tubule, loop of Henle, distal convoluted tubule, collecting duct. The localization of the anti-natriuretic effect of insulin to portions of the nephron distal to the site of proximal puncture in the above micropuncture studies is in agreement with free water clearance studies which suggest that the effect of insulin on sodium transport occurs in the distal convoluted tubule or the thick ascending limb of Henle [13, 14] . To define the precise tubular segment(s) involved, further studies employing combined distal and proximal micropuncture will be necessary.
Primary Versus Secondary Effect of Insulin on the Kidney
Two groups have attempted to define whether insulin exerts a direct effect on the kidney or whether its action is secondary to alterations in the hormonal or metabolic milieu to which the kidney is exposed [11, 15] . We have infused insulin directly into the left renal artery at a rate calculated to raise the local plasma insulin concentration by 215-287 nmol/l (or 30-40 mU/1) without significantly changing the systemic insulin concentration [11] . This resulted in a 50% decline in sodium excretion by the insulin perfused kidney without any change in sodium excretion by the contralateral kidney. Evidence for a direct effect of insulin on renal sodium handling has also been provided by Nizet et al. [15] . Using the isolated peffused kidney they observed that addition of insulin to the peffusing medium led to a prompt reduction in sodium excretion independent of changes in GFR and RPF. It would, thus, appear that the effect of insulin on the kidney is a direct one.
Insulin and Sodium Excretion in Man
The studies summarised above clearly demonstrate that physiological changes in the plasma insulin concentration are capable of affecting sodium transport in animals both in vivo and in vitro. Two groups have subsequently shown that insulin has similar antinatriuretic effect in man [2, 13] . Miller and Bogdonoff [2] were the first to demonstrate clearly that insulin administration in man could lead to a reduction in sodium excretion independent of changes in plasma glucose concentration. The time course of this effect was subsequently studied by our own group [13] . Following four 30-min control urine collections, euglycaemic hyperinsulinaemia (steady-state plasma insulin concentration = 1070 + 108 nmol/1 or (149 _+ 15 mU/1) was created employing the insulin clamp technique (Fig. 3) . Within 30 min of initiating the insulin infusion, a slight decrease in UNaV (P = 0.10) was observed and within 60 rain a highly significant reduction was documented. Over the subsequent hour UNaV continued to decline, reaching a value 50% less than that during the control period. This anti-natriuretic effect of insulin was observed in the absence of changes in the filtered load of glucose, GFR, RPF, and plasma aldosterone concentration.
Insulin and Sodium: Clinical Implications

Diabetes Mellitus
It is commonly stated that sodium wasting in poorly controlled diabetics results from glycosuria and the resultant osmotic diuresis. If significant ketonuria is present this may also contribute to the natriuresis since the negatively charged ketone body necessitates the excretion of an equivalent number of positively charged ions (primarily Na +, K +, NH4 +) to maintain electrical neutrality. A less well recognised factor, which may contribute to the excessive sodium wasting, is insulin lack per se. The data summarised in the first half of this review have clearly documented that physiological increases in the plasma insulin concentration induce sodium retention. Conversely, recent studies have shown that infusion of somatostatin, a potent inhibitor of insulin secretion, causes an increase in urinary sodium excretion [16] . Within the first hour following somatostatin infusion, plasma insulin levels declined by 45% from 144 to 79 nmol/1 (or 20-11 mU/l). This was associated with a small, transient decline in urinary sodium excretion. Thereafter, a sustained increase in UNa V ensued which persisted throughout the 4-h duration of study. In order to assess the contribution of insulin lack, Saudek et al. [17] studied six poorly controlled diabetics, only one of whom had significant ketonuria. At the time of admission sodium excretion was excessive. With the institution of insulin therapy, UNaV fell markedly and was well below the dietary intake. This initial decline in UNaV did not correlate with either the fall in plasma glucose concentration or the decline in urinary glucose excretion. However, the possibility that pre-existing sodium deficits were reponsible for the decline in UNa V now that the filtered glucose load had diminished could not be excluded. To examine this subjects were placed on a high sodium intake for 2 weeks and their daily insulin replacement was continued. On day 14, when insulin was discontinued, an abrupt increase in UNa V was observed. To avoid negative sodium balance the dietary sodium intake was increased to exceed urinary sodium losses. When insulin therapy was reinstituted on day 16, a marked decline in UNaV again occurred. Changes in glucose excretion were small and did not correlate with changes in UNa V. These results indicate that insulin lack per se, independent of glycosuria and ketonuria, contributes to the sodium wasting in poorly controlled diabetics.
Fasting and Refeeding
It is well known that following total starvation excessive renal sodium losses occur and that following refeeding marked sodium retention results [5, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . Several mechanisms have been put forward to account for these changes. During starvation significant changes in the hormonal and metabolic milieu in which the kidney is bathed occur [29, 30] . Plasma insulin levels decline and glucagon increases; ketonaemia, ketonuria, and metabolic acidosis develop and there are alterations in the activity of the sympathetic nervous system [31] . Changes in aldosterone secretion and sensitivity have also been postulated [32] [33] [34] [35] .
Kolanowski et al. have carried out the most extensive studies on the natriuresis of fasting and the anti-natriuresis associated with refeeding [5, [18] [19] [20] . They found that when obese subjects were placed on a constant, moderately restricted sodium intake containing no calories, UNaV increased to exceed intake by approximately 30-40 mmol of sodium/day for the first 3 days and then started to decline. However, even by day 7 of fasting, sodium excretion significantly exceeded sodium intake. If the same subjects were refed with oral or IV glucose on day 4 of fasting, a prompt and sustained reduction in UNaV ensued and all subjects went into positive sodium balance. These basic observations have been repeated by numerous investigators, using slightly different experimental designs [21-28; review by Weinsier 231.
Several hormonal factors have been implicated in the alterations in renal sodium handling following starvation and refeeding. During starvation glucagon levels rise and the time course of rise parallels the increase in UNa V. The converse occurs during refeeding. Since pharmacological doses of glucagon have been shown to increase sodium excretion [38] , it has been suggested that glucagon is the hormone responsible for the changes in sodium excretion following starvation and refeeding [32, 36, 37] . Recent studies by Kolanowksi, however, have made this hypothesis untenable [19] . If glucagon is administered with glucose on day 4 of starvation, the antinatriuresis of glucose persists. Other studies also suggest that changes in plasma glucagon levels within the physiological range have little effect on renal sodium handling [19, 38] . Changes in aldosterone secretion and/or sensitivity have also been suggested to play an important role in the altered sodium metabolism following caloric deprivation and refeeding [32] [33] [34] [35] . However, during the first 3 days of starvation, plasma aldosterone levels increase while sodium excretion also rise [18, 35, 39] . Furthermore, Kolanowski has demonstrated normal tubular responsiveness to aldosterone during this period of caloric deprivation [18] . In addition, spironolactone failed to block the natriuresis of fasting or the anti-natriuresis following refeeding [40] . Most recently, Landsberg and Young have demonstrated decreased sympathetic nervous system activity following starvation which is reversed following refeeding [31] . Since increased circulating catecholamines and stimulation of the renal sympathetic nerves are capable of enhancing sodium reabsorption by the kidney [41, 42] , it is possible that the natriuresis of starvation and its reversal following feeding are related to changes in circulating catecholamine levels or sympathetic nervous system activity. Further studies will be needed to clarify this potentially important relationship.
The last and most probable hormone responsible for the alterations in sodium balance following starvation and refeeding is insulin. Caloric deprivation is associated with a prompt decline in circulating insulin levels and carbohydrate refeeding is associated with a stimulation of insulin secretion [29] . Previous studies by our group have shown that inhibition of basal insulin secretion is followed by a natriuresis [16] and elevation of the plasma insulin concentration by as little as 215 nmol/1 (or 30 mU/1) is associated with an anti-natriuresis [11] . The changes in plasma insulin levels that occur in starvation and refeeding are well within the range reported by DeFronzo et al [11, 16] as affecting renal sodium excretion. It must be emphasised that hypoinsulinaemia is associated with two other important metabolic changes: metabolic acidosis and ketonuria, Previous studies have shown that both acute [43] and chronic [44] metabolic acidosis inhibit sodium reabsorption by the kidney. Studies by Stinebaugh and Schloeder [27] suggest that as much as one-third of the ensuing natriuresis following starvation may be due to the development of systemic acidosis. The inability of sodium bicarbonate administration to prevent the natriuresis [18, 45] does not exclude a role for metabolic acidosis since the blood pH was not measured in these studies. A better established factor contributing to the natriuresis of fasting is the development of ketonuria. During the first 3 days of fasting, the increase in sodium excretion closely parallels the increase in ketone excretion [20, 22] . During this time ammonium excretion increases little. Starting on day 4 of fasting ammonium excretion begins to increase markedly and ammonium replaces sodium as the predominant positively charged ion in the urine. If the fast is interrupted by glucose feeding, the decline in UNaV closely parallels the decline in ketone excretion. On the other hand, changes in ketone excretion cannot be the only factor reponsible for the changes in sodium metabolism following fasting and refeeding since protein feeding can similarly reduce sodium excretion despite persistent ketonuria. In summary, it would appear that insulin lack per se, ketonuria and perhaps metabolic acidosis all play important roles in the natriuresis of fasting and subsequent anti-natriuresis that follows re feeding.
Obesity and Hypertension
Much information has been accumulated that documents a markedly increased incidence of hypertension in obese individuals [46] [47] [48] [49] . Despite the fact that hypertension is a well-established risk factor for the development of coronary artery disease, little is known about the specific factors which are responsible for the high prevalence of high blood pressure in overweight individuals.
Blood pressure is primarily determined by two factors: cardiac output and the peripheral vascular resistance. Both of these are dependent on the total body sodium content and neurohormonal factors. Little is known about the contribution of the sympathetic nervous system and the renin-angiotensinaldosterone system to the hypertension observed in obesity. Several recent studies have suggested that hyperinsulinaemia, perhaps acting by enhanced renal sodium absorption, plays a causative role in the hypertension. Dahl et al. [50] examined the ability of three regimens: a) salt restriction; b) caloric restriction, and c) combined salt and caloric restriction to normalize the blood pressure in obese, hypertensive individuals. Salt restriction alone and combined saltcaloric restriction resulted in a near normalization of blood pressure, whereas caloric restriction while maintaining sodium balance was without effect. These results would suggest that it is sodium, not weight loss, which is associated with the reduction in blood pressure. It shuld be noted that this important study involved small numbers of patients (four to five) in each group and has yet to be repeated. Reisin et al. [51] have reached a different conclusion. They treated obese hypertensive subjects with a hypocaloric, normal salt diet and found a highly significant reduction in blood pressure. These authors concluded that it was the weight reduction per se that was responsible for the reduction in blood pressure. However, no measurements of sodium balance were made during the period of weight loss, and the maintenance of a normal dietary sodium intake does not exclude a significant negative sodium balance.
Several other studies [47, 48, 52, 53] have also reported reductions in blood pressure following weight reduction, but no attempt was made to assess sodium balance in any of these studies.
One factor that is common to all of these studies involving weight reduction is that the plasma insulin concentration fell significantly. It is well known that obesity is a state of insulin resistance and is characterized by fasting hyperinsulinaemia and excessive insulin secretion to glucose stimulation [54] . Fasting insulin levels in the 215-359 nmol/1 (30-50mU/1) range are not uncommon in obese individuals. Following caloric restriction and weight loss, there is a marked reduction in fasting and glucose-stimulated insulin levels [55, 56] . How might these changes in plasma insulin concentration be related to the improvement in blood pressure control? As discussed earlier, an increase in plasma insulin concentration of only 215 nmol/1 (30mU/1) can result in significant sodium retention. Thus, it is possible that the insulin resistance with respect to glucose metabolism leads to hyperinsulinaemia, which subsequently stimulates sodium reabsorption by the kidney and expands the extracellular fluid volume (Fig. 4) by Guyton et al. [57] and reviewed by Tobian [58] and Freis [59] , continued expansion of the extracellular fluid volume by salt and water will lead to an increase in cardiac output and rise in blood pressure (Fig. 4) . As the perfusion pressure to which the kidney is exposed increases, eventually the anti-natriuretic effect of insulin will be overcome and a natriuresis will ensue (Fig. 4) . However, as the extracellular fluid returns toward normal, blood pressure will tend to fall, sodium reabsorption will be stimulated, and the cycle will repeat itself. In some as yet unknown fashion, the body perceives the need to maintain an elevated blood pressure to prevent the excessive sodium retention that would otherwise occur with hyperinsulinaemia. There follows an increase in the peripheral vascular resistance which is then responsible for the sustained elevation in blood pressure. Insulin may also affect the peripheral vascular resistance directly by influencing sodium and/or calcium uptake by the arterial smooth muscle [60] .
When obese subjects are treated with a hypocaloric diet, plasma insulin levels fall [ These observations suggest that insulin, working through sodium, plays an important contributory role in the hypertension so commonly observed in obese subjects. The lack of improvement in blood pressure control following weight reduction when negative sodium balance was prevented from occurring offers support for this contention [50] . These observations stress the importance of weight reduction and amelioration of hyperinsulinaemia in the treatment of hypertension in the obese.
